ATE289804T1 - Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten - Google Patents
Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthaltenInfo
- Publication number
- ATE289804T1 ATE289804T1 AT99951810T AT99951810T ATE289804T1 AT E289804 T1 ATE289804 T1 AT E289804T1 AT 99951810 T AT99951810 T AT 99951810T AT 99951810 T AT99951810 T AT 99951810T AT E289804 T1 ATE289804 T1 AT E289804T1
- Authority
- AT
- Austria
- Prior art keywords
- chlorite
- hydrogen peroxide
- ophtahalmological
- dermatological
- preparations
- Prior art date
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title abstract 4
- 229910001919 chlorite Inorganic materials 0.000 title abstract 3
- 229910052619 chlorite group Inorganic materials 0.000 title abstract 3
- 230000000845 anti-microbial effect Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 title 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 abstract 2
- -1 peroxy compound Chemical class 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 208000004898 Herpes Labialis Diseases 0.000 abstract 1
- 206010067152 Oral herpes Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 230000003260 anti-sepsis Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000003405 delayed action preparation Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000036573 scar formation Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000036269 ulceration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/13—Burn treatment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16962098A | 1998-10-08 | 1998-10-08 | |
| PCT/US1999/023291 WO2000019981A1 (en) | 1998-10-08 | 1999-10-06 | Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE289804T1 true ATE289804T1 (de) | 2005-03-15 |
Family
ID=22616449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99951810T ATE289804T1 (de) | 1998-10-08 | 1999-10-06 | Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6488965B1 (de) |
| EP (1) | EP1119347B1 (de) |
| AT (1) | ATE289804T1 (de) |
| AU (1) | AU6416999A (de) |
| DE (1) | DE69923987T2 (de) |
| WO (1) | WO2000019981A1 (de) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6592907B2 (en) * | 1999-10-04 | 2003-07-15 | Hampar L. Karagoezian | Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| US20040037891A1 (en) * | 1999-10-04 | 2004-02-26 | Karagoezian Hampar L. | Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| US20070104798A1 (en) | 1999-10-04 | 2007-05-10 | S.K. Pharmaceuticals, Inc. | Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| WO2002005853A2 (en) | 2000-07-14 | 2002-01-24 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| US8858961B2 (en) | 2000-07-14 | 2014-10-14 | Allergan, Inc. | Compositions containing alpha-2-adrenergic agonist components |
| HU230383B1 (hu) * | 2000-07-14 | 2016-03-29 | Allergan, Inc | Oldékonyságfokozó komponens használata brimodinin-tartarátot tartalmazó vizes készítményekben |
| US20050177892A1 (en) * | 2001-02-12 | 2005-08-11 | Pioneer Hi-Bred International, Inc. | Maize Rar1-interactor polynucleotides and methods of use |
| PE20030263A1 (es) * | 2001-07-31 | 2003-04-17 | Novartis Ag | Composicion farmaceutica oftalmica |
| CA2462871C (en) * | 2001-10-05 | 2013-07-02 | Steris Inc. | In vitro model for priocidal activity |
| KR100444893B1 (ko) * | 2001-12-24 | 2004-08-21 | 주식회사 화이투스 | 치약 조성물 |
| US20050142215A1 (en) * | 2002-03-27 | 2005-06-30 | Kling William O. | Antimicrobial compositions and methods of use |
| JP4244129B2 (ja) * | 2002-10-28 | 2009-03-25 | 株式会社メニコン | 消毒方法 |
| US20040137079A1 (en) * | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
| US7087190B2 (en) | 2003-03-20 | 2006-08-08 | Ecolab Inc. | Composition for the production of chlorine dioxide using non-iodo interhalides or polyhalides and methods of making and using the same |
| US20040191332A1 (en) * | 2003-03-27 | 2004-09-30 | Allergan, Inc. | Preserved ophthalmic compositions |
| US7071152B2 (en) * | 2003-05-30 | 2006-07-04 | Steris Inc. | Cleaning and decontamination formula for surfaces contaminated with prion-infected material |
| CA2839847C (en) * | 2003-06-13 | 2016-03-15 | Masood A. Chowhan | Ophthalmic compositions containing a synergistic combination of two polymers |
| US7947295B2 (en) | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
| US7486989B2 (en) * | 2003-06-30 | 2009-02-03 | Johnson & Johnson Consumer Companies, Inc. | Device for delivery of oxidizing agents to barrier membranes |
| US7479133B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating acne and rosacea with galvanic generated electricity |
| US20040265395A1 (en) * | 2003-06-30 | 2004-12-30 | Ying Sun | Device for delivery of reducing agents to barrier membranes |
| US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
| US7477939B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating a wound with galvanic generated electricity |
| US7477938B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Cosumer Companies, Inc. | Device for delivery of active agents to barrier membranes |
| US7480530B2 (en) * | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
| US7477941B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of exfoliating the skin with electricity |
| US7507228B2 (en) * | 2003-06-30 | 2009-03-24 | Johnson & Johnson Consumer Companies, Inc. | Device containing a light emitting diode for treatment of barrier membranes |
| US7477940B2 (en) * | 2003-06-30 | 2009-01-13 | J&J Consumer Companies, Inc. | Methods of administering an active agent to a human barrier membrane with galvanic generated electricity |
| US7476222B2 (en) * | 2003-06-30 | 2009-01-13 | Johnson & Johnson Consumer Companies, Inc. | Methods of reducing the appearance of pigmentation with galvanic generated electricity |
| US8257780B2 (en) * | 2003-10-31 | 2012-09-04 | Resource Development L.L.C. | Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using |
| US6994890B2 (en) * | 2003-10-31 | 2006-02-07 | Resource Development L.L.C. | Cleaning and multifunctional coating composition containing an organosilane quaternary compound and hydrogen peroxide |
| DE602004025264D1 (de) * | 2003-11-05 | 2010-03-11 | Johnson & Johnson Vision Care | Methoden zur vermeidung des klebens von linsen an ihren verpackungen |
| CN101072592B (zh) * | 2004-10-07 | 2012-03-14 | 恩根医药有限公司 | 液体组合物在制备用于局部治疗开放伤和烧伤的药物中的用途 |
| US20080274206A1 (en) * | 2004-10-07 | 2008-11-06 | Ngen Pharmaceuticals N.V. | Stabilised Oxygen Releasing Composition |
| JP5154231B2 (ja) | 2005-02-14 | 2013-02-27 | ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド | 快適な眼科用具およびその製造法 |
| US20070048388A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| EP1979269A4 (de) * | 2005-12-22 | 2013-01-02 | Taiji Biomedical Inc | Chloritformulierungen und verfahren zur herstellung und verwendung davon |
| US9052529B2 (en) | 2006-02-10 | 2015-06-09 | Johnson & Johnson Vision Care, Inc. | Comfortable ophthalmic device and methods of its production |
| US20070238630A1 (en) * | 2006-03-29 | 2007-10-11 | Phillips Douglas H | Subcutaneous skin cleanser |
| US20090239954A1 (en) * | 2008-03-19 | 2009-09-24 | Collins Gary L | Phosphate buffered ophthalmic solutions displaying improved efficacy |
| US8150525B2 (en) | 2008-08-27 | 2012-04-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment of hyperhydrosis |
| US20100226999A1 (en) * | 2009-03-06 | 2010-09-09 | Tracy Quevillon-Coleman | Process for forming stabilized ophthalmic solutions |
| US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
| US20100284951A1 (en) * | 2009-05-07 | 2010-11-11 | Thavisith Pongprapansiri | Novel compositions for the treatment of wounds and skin care |
| KR20120091335A (ko) | 2009-11-13 | 2012-08-17 | 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 | 갈바닉 피부 치료 장치 |
| CA2775969C (en) * | 2009-11-17 | 2016-12-20 | Novartis Ag | A hydrogen peroxide solution and kit for disinfecting contact lenses |
| US8735618B2 (en) | 2010-05-07 | 2014-05-27 | Resource Development L.L.C. | Solvent-free organosilane quaternary ammonium compositions, method of making and use |
| MX2014007664A (es) * | 2011-12-22 | 2015-05-11 | Nuvo Res Gmbh | Composiciones liposomicas de clorito o clorato. |
| CH710357A1 (de) * | 2014-11-11 | 2016-05-13 | Bogaert Jean-Pierre | Kosmetisches und pharmazeutisches Mittel zur Behandlung von Hautrissen. |
| WO2016135219A1 (en) | 2015-02-26 | 2016-09-01 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | Topical composition for the treatment of mucosal lesions |
| US10835584B2 (en) * | 2016-06-17 | 2020-11-17 | Nuvothera, Inc. | Systems for treating dermal inflammatory conditions |
| US20190262498A1 (en) * | 2016-07-27 | 2019-08-29 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | Bioadhesive platform to perform bioactive treatment |
| WO2018108256A1 (en) | 2016-12-13 | 2018-06-21 | Stahl Kurt Wilhelm | Composition for dressing cutaneous lesions and manufacturing method thereof |
| IL275980B2 (en) | 2018-01-14 | 2023-10-01 | Collidion Inc | Compounds, kits, methods and uses for cleaning, disinfection, sterilization and/or treatment |
| JP7490570B2 (ja) * | 2018-04-27 | 2024-05-27 | アラーガン、インコーポレイテッド | 抗微生物有効性の増強及び毒性の減少を有する亜塩素酸ナトリウム組成物 |
| DE102019101434A1 (de) * | 2019-01-21 | 2020-07-23 | Hager & Werken Gmbh & Co Kg | Zusammensetzung zur Behandlung oder Prävention von Infektionen und Entzündungen |
| CN112057351B (zh) * | 2020-09-22 | 2023-01-24 | 西安诗莱梦特生物科技有限公司 | 透明质酸-羟丙基甲基纤维素复合水凝胶及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR959544A (de) * | 1947-02-01 | 1950-03-31 | ||
| US3082146A (en) * | 1959-02-04 | 1963-03-19 | Chemical Res Lab Of America In | Process for the treatment of water |
| US3585147A (en) * | 1969-10-01 | 1971-06-15 | Int Dioxcide Inc | Stabilized chlorine dioxide solutions containing a chloride and processes of making and using same |
| US4317814A (en) * | 1980-06-12 | 1982-03-02 | Felipe Laso | Preparation and method for treating burns |
| US4296102A (en) * | 1980-06-12 | 1981-10-20 | Felipe Laso | Method of combating amebiasis in humans |
| US4670185A (en) * | 1982-07-19 | 1987-06-02 | Lion Corporation | Aqueous vesicle dispersion having surface charge |
| US4574084A (en) * | 1983-02-25 | 1986-03-04 | Peter Berger | Process for the preparation of a modified aqueous chlorite solution, the solution prepared by this process and the use thereof |
| US4891216A (en) * | 1987-04-14 | 1990-01-02 | Alcide Corporation | Disinfecting compositions and methods therefor |
| US4880638A (en) * | 1988-08-23 | 1989-11-14 | Bioxy International, Ltd. | Biocidal composition and method for disinfecting articles |
| US5078908A (en) * | 1989-10-02 | 1992-01-07 | Allergan, Inc. | Methods for generating chlorine dioxide and compositions for disinfecting |
| JPH06206825A (ja) * | 1992-12-11 | 1994-07-26 | Nippon Rooshiyon Kk | 白癬菌、湿疹等による皮膚病の治療剤及び 皮膚殺菌活性化剤 |
| US5736165A (en) * | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
| US5855922A (en) * | 1995-12-07 | 1999-01-05 | Bio-Cide International, Inc. | Antiseptic composition and process for prophylaxis and therapeutic treatment of dermal disorders |
-
1999
- 1999-10-06 WO PCT/US1999/023291 patent/WO2000019981A1/en not_active Ceased
- 1999-10-06 DE DE69923987T patent/DE69923987T2/de not_active Expired - Lifetime
- 1999-10-06 AU AU64169/99A patent/AU6416999A/en not_active Abandoned
- 1999-10-06 AT AT99951810T patent/ATE289804T1/de not_active IP Right Cessation
- 1999-10-06 EP EP99951810A patent/EP1119347B1/de not_active Expired - Lifetime
-
2000
- 2000-11-27 US US09/722,919 patent/US6488965B1/en not_active Expired - Lifetime
-
2014
- 2014-09-10 US US14/482,894 patent/US20150056272A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US6488965B1 (en) | 2002-12-03 |
| EP1119347A1 (de) | 2001-08-01 |
| EP1119347B1 (de) | 2005-03-02 |
| DE69923987T2 (de) | 2006-11-02 |
| EP1119347A4 (de) | 2003-06-04 |
| AU6416999A (en) | 2000-04-26 |
| DE69923987D1 (de) | 2005-04-07 |
| US20150056272A1 (en) | 2015-02-26 |
| WO2000019981A1 (en) | 2000-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE289804T1 (de) | Synergistische antimikrobielle. dermatologische und ophtahalmologische zubereitungen, die ein chlorit und wasserstoffperoxid enthalten | |
| US7276255B2 (en) | Wound and ulcer treatment with super-oxidized water | |
| JP5816406B2 (ja) | 酸化還元電位水溶液を使用する皮膚潰瘍の治療方法 | |
| US5855922A (en) | Antiseptic composition and process for prophylaxis and therapeutic treatment of dermal disorders | |
| Sebben | Surgical antiseptics | |
| MX2009005836A (es) | Preparaciones antimicrobianas sinergisticas que contienen clorito y peroxido de hidrogeno. | |
| ATE214933T1 (de) | Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten | |
| AU2002322298A1 (en) | Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide | |
| Gold et al. | Hypochlorous acid gel technology—Its impact on postprocedure treatment and scar prevention | |
| EP1005320A4 (de) | Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände | |
| Brown et al. | A review of topical agents for wounds and methods of wounding: guidelines for wound management | |
| EP1787650A3 (de) | Therapeutische Zusammensetzung mit einer quaternären Organosilanverbindung und Wasserstoffperoxid für die Behandlung von Hautproblemen | |
| WO2012150477A2 (en) | Medical uses of nanoclustered water | |
| AR058821A1 (es) | Metodos, sistemas y composiciones de tratamiento graduables por el usuario para el tratamiento del acne | |
| CA2157836A1 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
| WO2002074290B1 (en) | Dermatological preparations containing a nsaid | |
| ES2127613T3 (es) | Utilizacion de un antagonista de tnf-alfa para el tratamiento de rojeces cutaneas de origen neurogeno. | |
| CZ178196A3 (en) | Pharmaceutical preparation for papulopustular punctual therapy | |
| Natarelli et al. | Hypochlorous acid: Applications in dermatology | |
| CN101163491B (zh) | 利用氧化还原电位水溶液治疗皮肤溃疡的方法 | |
| US20190125790A1 (en) | Use of hypochlorous acid as a topical antimicrobial | |
| IE44070L (en) | Polyamines. | |
| PL334679A1 (en) | Application of dichlorobenzyl alcohol in production of preparations useful in locally treating inflammatory states as well as preparation useful in loacally treating inflammatory states as well as preparation containing such alcohol | |
| CA2404210A1 (en) | Pharmaceutical gel composition | |
| Scanlon et al. | To use or not to use? The debate on the use of antiseptics in wound care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |